International Journal of Cardiology

Article	Citations
Three-dimensional echocardiography reveals early mitral valve alterations in hypertrophic cardiomyopathy genetic mutation carriers	168
Signature of standard modifiable CV factors as unrecognizable risk factor of in-hospital mortality in patients with acute myocardial infarction	108
Mitral valve reoperation: Refining risk stratification for better outcomes	103
Sudden death of an athlete with concealed arrhythmogenic cardiomyopathy	98
Contemporary outcomes of surgical aortic valve replacement in patients referred for a transcatheter approach	86
Using machine learning to guide imaging in hypertrophic cardiomyopathy - from lessening the burden of our day-to-day clinical decisions to more cost-effective resource utilization	80
The association of bisphosphonates, calcium levels and PTH levels with bioprosthetic aortic valve degeneration	79
Prognostic value of exercise tolerance and exercise-induced diastolic dysfunction in elderly patients referred for exercise stress echocardiography	78
Impact of veno-venous collaterals on outcome after the total cavopulmonary connection	75
Targeting the SPP1/TGF-β1 axis in macrophages: A potential therapeutic mechanism for atrial fibrillation?	74
From gatekeeper to game-changer? Rethinking FFRCT in revascularization strategy	71
Editor's note	68
Apical ballooning and the rogue clot: A risky affair in Takotsubo syndrome	68
More cardiopulmonary effort testing needed in HFpEF!	64
Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study)	53
Utilization rates and heart transplantation outcomes of donation after circulatory death donors with prior cardiopulmonary resuscitation	53
Electroanatomical voltage mapping with contact force sensing for diagnosis of arrhythmogenic right ventricular cardiomyopathy	50
Fibroblast growth factor 5 as a target for atrial fibrillation treatment: Evidence from mendelian randomization	49
Metabolic disorders as growing risk factors and comorbidities in heart failure	46
Right ventricular strain in Fabry disease: Prognostic implications	46
Angiography-derived index of microcirculatory resistance as a novel tool to assess coronary microvascular dysfunction in patients with diabetic cardiomyopathy	46
Temporal progression of replacement and interstitial fibrosis in optimally managed dilated cardiomyopathy patients: A prospective study	46
Anticoagulation control in Malaysia: Reports of time in therapeutic range, bleeding, and thromboembolic complications	45
Non-hyperemic, non pressure wire, coronary physiology. A further step towards the generalization of physiology in the cath-lab?	45
Levosimendan versus dobutamine in acute heart failure: Insight into short and long term mortality	44

The total thrombus-formation analysis system in infective endocarditis patients undergoing valve replacement: Does it have predictive value?	43
Female, the dominant gender– a study of the Serdang Pulmonary Hypertension Registry	42
Elevated lipoprotein (a) another significant predictor of first-onset myocardial infarction among Malaysian adults	40
Potential mechanisms uncovered for the cardioprotective effects of high-intensity interval training	40
Indications, implications and safety of cardiovascular magnetic resonance (CMR) imaging in Malaysian population from the Multicentre Malaysian CMR Registry	40
Spontaneous coronary artery dissection: A look back to build momentum	37
P 013: Purulent pericardial effusion: A rare and silent life-threatening disease	37
TASH Two TASH	37
Myocardial infarction with no obstructive coronary artery (MINOCA): Prevalence, demographic pattern and 1-month outcome from Serdang PPCI STEMI Registry over 7 years	37
Can cuproptosis-related genes be involved in the pathogenesis of dilated cardiomyopathy?	36
Sex-related differences among young adults with heart failure: Does sex matter?	36
P 032: Acute ruptured chordae tendinea in infective endocarditis	36
Editorial Board	35
Burden of Rheumatic Heart Disease as a Barometer of Effective Policy Implementation	35
Acute heart failure admission and outcome: A single centre contemporary appraisal	35
The effects of Thrombospondin-1 on cardiovascular disease: Friend or foe?	35
Critical aortic stenosis – The long-term burden	34
Clinical implication of hypoalbuminemia in acute heart failure: Insights from Malaysia Heart Failure (MyHF) Registry	34
The use of bisoprolol in treatment for heart failure and its effects of dose titration on blood pressure and heart rate	34
Letter to the editor: “Performance evaluation of four scoring systems for mortality prediction in a contemporary cardiac intensive care unit”	33
Signal-morphology impedance cardiography is a non-invasive tool for predicting responses to exercise-based cardiac rehabilitation	33
CD163-positive macrophage enrichment in cardiogenic thrombi from atrial fibrillation than in atherosclerotic thrombi from sinus rhythm	33
Periprocedural anticoagulation therapy in patients undergoing micra leadless pacemaker implantation	33
Changes of left ventricular remodeling due to increased afterload in patients with essential hypertension	33
Corrigendum to “Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology” [International Journal of Cardiology Volume 364, 1 October 2022,	32
Direct oral anticoagulants versus percutaneous left atrial appendage occlusion in atrial fibrillation: 5-year outcomes	32
WITHDRAWN: Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension: A systematic review and network meta-analysis	32
Corrigendum to “Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis” [International Journal of Cardiology Volume 357, 15 June 2022, Pages 88–94].	32
A novel diagnostic model for fetal coarctation of the aorta with ventricular septal defect	32
Cardiovascular outcomes with SGLT-2 inhibitors in individuals with diabetes and co-existing atrial fibrillation: A systematic review and meta-analysis	31
Drug-induced increase in dispersion of ventricular repolarization in patients with heart failure with preserved ejection fraction	30
Prevalence and determinants of tricuspid regurgitation after repair of tetralogy of Fallot	30
Effect of PCSK9 antibodies on coronary plaque regression and stabilization derived from intravascular imaging in patients with coronary artery disease: A meta-analysis	30
Impact of veno-venous collaterals on outcome after the total cavopulmonary connection	30
Letter to the editor: Prediction of adverse cardiovascular events in children using artificial intelligence-based electrocardiogram	30
Left ventricular diastolic dysfunction in patients with heart failure with mildly reduced ejection fraction	29
From assumed rarity to measured reality: Inherited cardiac diseases and sudden cardiac death	29
Optical coherence tomography factors for adverse events in patients with severe coronary calcification	29
Supra-renal aortic atheroma extent and composition predict acute kidney injury after transcatheter aortic valve replacement: A three-dimensional computed tomography study	29
Predicting functional results of percutaneous coronary intervention using machine learning modelling	28
Difficult-to-treat recurrent pericarditis after SARS-CoV-2 vaccination	28
Functional tricuspid regurgitation: A clustering analysis and prognostic validation of three echocardiographic phenotypes in an external cohort	28
Precipitating factors in patients with spontaneous coronary artery dissection: Clinical, laboratoristic and prognostic implications	28
Coronary angiography- or fractional flow reserve-guided complete revascularization in multivessel disease STEMI: A Bayesian hierarchical network meta-analysis	28
Circulating progenitor cells and outcomes in patients with coronary artery disease	27
Frailty in acute coronary syndromes. A systematic review and narrative synthesis of frailty assessment tools and interventions from randomised controlled trials	27
Characteristics of patients with suspected cardiac amyloidosis in Tuscany and Umbria: Insights from the cardiac amyloidosis RegistRY (CARRY)	27
Pericardium, epicardial adipose tissue, and heart failure with preserved ejection fraction: Pathophysiology, quantification and treatment target	27
Perspectives in noninvasive imaging for chronic coronary syndromes	26
Virtual reality-assisted distraction during transcatheter aortic valve implantation under local anaesthesia: A randomised study	26

Four-factor prothrombin complex concentrate (4F-PCC) in warfarin reversal: A prospective observational study	26
Downstream cangrelor versus upstream ticagrelor in patients with ST-segment elevation myocardial infarction: A propensity score-matched analysis	26
Comparison of diagnostic performance of non-invasive FFR in diabetes mellitus and non-diabetic patients	26
A comprehensive demographics and outcome audit of Complete Heart Block cases at Hospital Teluk Intan in 2024	26
Mortality after catheter ablation of structural heart disease related ventricular tachycardia	26
Patterns of atrial fibrillation, relevant cardiac structural and functional changes predict functional and cognitive outcomes in patients with ischemic stroke and atrial fibrillation	25
Domain-specific association of single-nucleotide variants in the LMNA gene with the phenotypic expression of dilated cardiomyopathy	25
Letter to the editor: Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study	25
Assessment of the left atrial volume and function following percutaneous mitral balloon valvuloplasty: Insights into acute and late impact of atrial fibrillation on atrial remodeling	25
Reply to “Tertiary-centric data and AMI-CS care: Does it reflect real-world adherence?”	25
Response to the letter to the editor regarding “Changes in syndecan-1 concentration in the coronary sinus immediately after cardiac reperfusion reflect postoperative myocardial injury”	25
Resurrection of classical antiarrhythmic drugs	25
Letter to “Trajectory, correlates, and outcomes of pulmonary congestion by lung ultrasound in patients hospitalized for acute pulmonary edema”	25
Heart failure management guided by remote multiparameter monitoring: A meta-analysis	24
A hybridization of XGBoost machine learning model by Optuna hyperparameter tuning suite for cardiovascular disease classification with significant effect of outliers and heterogeneous training dataset	24
Trends in immune checkpoint inhibitor related myocarditis: A decade of insights	24
Swiss Evaluation Registry for Pediatric Infective Endocarditis (SERPIE) - Risk factors for complications in children and adolescents with infective endocarditis	24
Application of machine learning algorithms in electronic medical records to predict amputation-free survival after first revascularization in patients with peripheral artery disease	24
Early combination therapy with trimetazidine rapidly improves symptoms and quality of life in patients recently diagnosed with stable angina: The COMBINE angina study	24
Clinical outcomes, management, healthcare resource utilization, and cost according to the CHA2DS2-VASc scores in Asian patients with nonvalvular atrial fibrillation	24
Sex differences outcomes in conduction system pacing for patients with typical left bundle branch block	24
Heparin dosing in patients with Impella-supported cardiogenic shock	23
High low-density lipoprotein cholesterol levels in people with HIV by individual cardiovascular risk: A retrospective observational study	23
Aortic root/left ventricular diameters golden ratio in competitive athletes	23
Role of speckle tracking echocardiography beyond current guidelines in cardiac resynchronization therapy	23
Admission and discharge sodium: Chloride ratio in acute heart failure – The importance of electrolytes	23
The axillary vein puncture for implantable cardiac defibrillator implantation: 14 years of experience. Analysis of the results	23
Beyond the heart: Mind-body connection from birth and the holistic intervention in cardiovascular care	23
Innate and adaptive immunity in acute myocarditis	22
Association between QRS shortening and mortality after cardiac resynchronization therapy: Results from the DANISH study	22
Inflammation in chronic kidney disease – Something old, something new	22
Plasma expression level of Hsa_circ_0099734 is associated with atrial fibrillation and its poor prognosis	22
Comparative efficacy of vericiguat to sacubitril/valsartan for patients with heart failure reduced ejection fraction: Systematic review and network meta-analysis	22
Is primary PCI failing women? An 8-year retrospective study evaluating gender effects on 30-day mortality in ST elevation myocardial infarction	21
Reply to: Kavsak et al. The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction	21
Temporal variations in ischemic and bleeding event risks after acute coronary syndrome during dual antiplatelet therapy	21
Inadequate Intensification of LDL-cholesterol lowering therapy after coronary revascularization: Insights from the GOULD registry	21
Left atrial strain is associated with arrhythmia recurrence after atrial fibrillation ablation: Cardiac magnetic resonance rapid strain vs. feature tracking strain	21
Intervention needs assessment in children with heart diseases presenting to Tibebe-Ghion Specialized Teaching Hospital, Bahir Dar, North West Ethiopia – Tip of the iceberg of the intervention gap in L	21
Mortality trend of ischemic heart disease (2008–2022): A retrospective analysis of epidemiological data	21
Navigating upstream and downstream: Unleashing the prognostic potential of RVFWLS/PASP ratio in severe tricuspid regurgitation	21
An age-centric evaluation of heart failure management: A comparative study in Sarawak	21
Could interleukin-1 receptor antagonist be a reliable predictor of prognosis in acute myocardial infarction?	21
Editorial Board	21
Letter to “Non-vitamin K antagonist oral anticoagulants (NOACs) and risk of spontaneous intracranial hemorrhage in patients with ischemic stroke: An analysis using Taiwan’s National Health Insurance R	21
Biomarkers in paroxysmal atrial fibrillation during an acute episode: The cause or the result?	20
Letter to the editor: Utilization rates and determinants of PYP and CMR among patients with unexplained left ventricular hypertrophy on echocardiography	20
The authors' reply to the letter “CA125 a cause or an effect in heart failure?”	20
Characteristics of patients with intradialytic hypotension in North Kuala Lumpur and the prevalence of coronary artery disease among them	20
High bleeding risk (HBR) in contemporary percutaneous coronary intervention (PCI) Malaysian Cohort	20
P 031: Successful treatment of radiation pericarditis with corticosteroid	20
Letter to the editor: Physical activity characteristics in adults with bicuspid aortic valve versus age and sex matched controls	20
Prognostic value of CMR-derived ECV in MINOCA patients: Progress and remaining challenges	20
Benefits of cardiac rehabilitation on cardiovascular outcome in patients post acute coronary syndrome	20
Safety and efficacy of renal denervation (RDN) in treatment of resistant hypertension: A single centre, 1 year observational study	20
Clinical relevance of coronary microvascular dysfunction following rotational Atherectomy	20
The CNIC polypill (Acetylsalicylic acid + Atorvastatin + Rampril) in secondary prevention of cardiovascular disease in patients with type 2 diabetes: A comparative analysis with alternative therapeuti	20
Educational tools may turn into decision-making strategies in clinical practice – The case of primary percutaneous coronary intervention risk scores	20
Catheter ablation versus medical therapy for atrial fibrillation- single centre, retrospective study	20
Small coronary artery matters: Non-dominant right coronary artery and perfusion imaging	20
REACHing conclusions on the external applicability of the THEMIS into clinical practice	19
P 004: As subtle as it can be-OMI paradigm, another myocardium saved	19
HOTAIR functions as a ceRNA to aggravate myocardial fibrosis through the miR-141/wnt5a axis	19
Editorial Board	19
Editorial Board	19
Reply to “Letter to the editor: Incidence of de novo malignancy and all-cause mortality among heart transplant recipients”	19
Editorial Board	19
Quality of anticoagulation control among patients receiving vitamin K antagonist in pharmacist-managed anticoagulation medication therapy adherence clinic	19
Procedural setting of percutaneous coronary intervention in Malaysia during the SARS-COV-2 pandemic – data from The National Heart Association of Malaysia's NCVD-PCI Registry	19
Editorial Board	19
Precision medicine in the treatment of STEMI patients – it's time for coronary physiology!	19
Impact of hospitalisation burden on mortality in adult congenital heart disease: A nationwide population study	19
Percutaneous coronary intervention from COURAGE to ISCHEMIA and beyond	19
Isolated tricuspid valve surgery: The devil is infective endocarditis?	19
No effect of remoteness on clinical outcomes following myocardial infarction: An analysis of 43,729 myocardial infarctions in Victoria, Australia	19
Lessons from rare cardiomyopathies: The importance of a phenotype-based approach to arrive at a specific diagnosis	19
The miR-26b/CTGF axis: A promising therapeutic mechanism for managing myocardial fibrosis post myocardial infarction	19
Clinical impact of multiple resheathing during transcatheter aortic valve implantation with Evolut self-expanding valves	19
Supported PCI reduced one-year all-cause mortality compared to standard PCI?	19
Unveiling the link between plasma proteome and cardiac function: A leap forward in heart failure research	18

Left atrial function's evaluation in aortic stenosis: A clinical imperative	18
Associations of cardiac function and arterial stiffness with cerebrovascular disease	18
Long-term outcomes of tricuspid valve plasty vs. replacement after cardiac surgery: Mortality, reoperation, and anticoagulation complications in patients with postoperative tricuspid regurgitation	18
Stuck, slow, and saving flow: One PCI, multiple challenges	18
Corrigendum to “Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine” [International Journal of Cardiology Volume 418, 1 January 2025, 132663]	18
Favorable impact of FFRCT on myocardial revascularization outcomes: Results from an observational real-world registry	18
Multimodality imaging in arrhythmogenic cardiomyopathy - From diagnosis to management	18
Change in exercise capacity after cardiac rehabilitation following coronary heart disease in patients with and without diabetes: A follow-up study	18
Prevalence and clinical impact of baseline atherosclerotic vascular disease in patients undergoing transcatheter aortic valve implantation: A meta-analysis	18
Monitoring and treatment of hypercholesterolemia after an atherosclerotic cardiovascular disease event in Denmark from 2015 to 2020	18
Ten-year outcomes post percutaneous coronary intervention in cardiac transplant recipients	18
LncRNA TUG1 regulates autophagy in atherosclerosis by sponging miR-145-5p	18
Worsening tricuspid regurgitation after mitral valve surgery: a meta-analysis and meta-regression	18
Do SGLT2 inhibitors protect elderly patients from HF rehospitalization and CKD progression? More opportunities than concerns	18
Addressing the unmet needs of cardiovascular evaluation in athletes: A national survey of the Italian Society of Cardiology (SIC) and the Regional Associations of Ambulatory Cardiologists (ARCA)	18
Reply to ‘unveiling the link between plasma proteome and cardiac function: A leap forward in heart failure research’	18
A simplified echocardiographic formula to estimate cardiac index in the intensive care unit	18
Pre-procedural oral anticoagulant use is associated with cardiovascular events in women after transcatheter aortic valve replacement: An analysis from the WIN-TAVI cohort	18
From blood clots to quick fixes: The availability of oral anticoagulants and their reversal in Ministry of Health Hospitals, Malaysia	18
How cardiologists can manage excess body weight and related cardiovascular risk. An expert opinion	17
Effect of beta-blockers and angiotensin receptor blockers in reducing the aortic growth rate in children with bicuspid aortic valve-related aortopathy	17
The association of inflammatory biomarkers and long-term clinical outcomes in older adults with non-ST elevation acute coronary syndrome	17
Impact of sex on Transcatheter aortic valve replacement outcomes: Results of a single-center study	17
Early glucagon-like peptide-1 receptor agonist use after myocardial infarction in patients with type 2 diabetes	17
Oral health behavior associated with cardiometabolic outcomes: A nationally representative cross-sectional study in Portugal	17
Coronary calcifications are the growth rings of coronary atherosclerotic plaque	17
Editorial Board	17
Corrigendum to “Potential of68Ga-FAPI-04 PET/MR to predict worsening renal function after acute ST-elevation myocardial infarction” [International journal of cardiology vol. 414 (2024): 132425]	17
ST Elevation is a poor surrogate for acute coronary occlusion. Let's Replace STEMI with Occlusion MI (OMI)!!	17
Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program	17
Long-term temporal trend in plaque eccentricity assessed through intravascular ultrasound imaging after heart transplantation	17
Spontaneous coronary artery dissection and ST-segment elevation myocardial infarction: Does clinical presentation matter?	17
Left atrial strain and risk of atrial fibrillation after coronary artery bypass-grafting	17
Microvascular vasomotor dysfunction is more prevalent in female versus epicardial vasomotor dysfunction in male ANOCA patients	17
Aerobic fitness change with time in children with congenital heart disease: A retrospective controlled cohort study	17
Erratum to “Chemokine-like receptor 1 deficiency impedes macrophage phenotypic transformation and cardiac repair after myocardial infarction” [International Journal of Cardiology 372C (2023) 6–14]	17
Single-pill combination in the management of chronic coronary syndromes: A strategy to improve treatment adherence and patient outcomes?	17
Is anion gap helpful for assessing cardiovascular risk in cardiac intensive care unit?	17
Outcomes of the Qatar Transcatheter aortic valve implantation- registry (QATAVI-registry) –first report 24/7/2024	17
Exercise capacity following SARS-CoV-2 infection is related to changes in cardiovascular and lung function in military personnel	17
Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study	17
The real-world safety of sacubitril / valsartan among older adults (≥75): A pharmacovigilance study from the FDA data	17
Cardiac remodeling and arterial stiffness progression in wild-type vs hereditary transthyretin amyloidosis in Crete	17
Subclinical myocardial work impairment in non-diabetic overweight and obese individuals: Impact of cardiometabolic traits	16
Effectiveness of Vericiguat on right ventricle to pulmonary artery uncoupling associated with heart failure with reduced ejection fraction	16
Hemodynamic effects of balloon pulmonary angioplasty for the treatment of total and subtotal pulmonary artery occlusions in inoperable chronic thromboembolic pulmonary hypertension	16
Genetic association between inflammatory factors and abdominal aortic calcification: Insights from a genome-wide association study	16
Psychosocial distress and health status as risk factors for ten-year major adverse cardiac events and mortality in patients with non-obstructive coronary artery disease	16
Trends in mechanical circulatory support utilization, left ventricular assist device implantation and transplant during cardiogenic shock hospitalizations, after the new heart allocation policy	16
Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine	16
Multivessel revascularization in non-ST segment elevation acute coronary syndromes: A systematic review and meta-analysis of 182,798 patients	16
High-sensitivity C-reactive protein, plaque vulnerability and adverse events in patients with stable coronary disease: An optical coherence tomography study	16
Clinical characteristics, management, diagnostic findings, and various etiologies of patients with Kounis syndrome. A systematic review	16
Left ventricular morphologic progression in apical hypertrophic cardiomyopathy	16
The [99mTc]Tc-HMPAO-labelled white blood cell SPECT/CT as a novel criterion for infective endocarditis diagnosis	16
MicroRNA-29b regulates pyroptosis involving calcific aortic valve disease through the STAT3/SOCS1 pathway	16
Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry	16
Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience	16
A hybrid machine learning approach using particle swarm optimization for cardiac arrhythmia classification	16
Heart failure with preserved ejection fraction in atrial functional mitral regurgitation – Insight from the REVEAL-AFMR	16
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy	16
Sex- specific differences in suspected myocarditis presentations and outcomes	16
Association between blood pressure response index and mortality in decompensated heart failure: A real-world study	16
Echocardiographic detection of heart valve disease in a community cohort of asymptomatic Australians > 65 years with cardiovascular risk factors	16
Patterns of aortic valve replacement in Europe and adoption by sex	16
Neo 2 transcatheter heart valve system: Direct towards a minimalistic procedure	15
Atrioventricular node ablation and pacing for atrial tachyarrhythmias: A meta-analysis of postoperative outcomes	15
Disparities in the management of non-ST-segment elevation myocardial infarction in the United States	15
Sex-specific disparities in catheter-directed therapies for pulmonary embolism	15
LncRNA HOTAIR promotes myocardial fibrosis in atrial fibrillation through binding with PTBP1 to increase the stability of Wnt5a	15
Comment on: Validation of a non-invasive device for measuring filling pressure against invasive pulmonary capillary wedge pressure	15
Impact of radiofrequency versus cryoballoon ablation on left atrial calcification after atrial fibrillation ablation: A propensity score-matched comparison	15
Galectin-3 contributes to acute cardiac dysfunction and toxicity by increasing oxidative stress and fibrosis in doxorubicin-treated mice	15
Dynamic glycemic monitoring and systemic inflammation assessment: New insights into plaque characteristics in acute myocardial infarction	15
Ultrasound-targeted microbubble destruction rapidly improves left ventricular function in rats with ischemic cardiac dysfunction	15
Clinical impact of work-related musculoskeletal disorders (WRMSD) among echocardiographer	15
Racial differences in natriuretic peptide levels in wild type transthyretin amyloid cardiomyopathy	15
Precision targeting of PERK in ischemia/reperfusion: Unresolved temporal dynamics and lipid transport mechanisms	15
Electrocardiographic findings in pediatric versus young-adolescent athletes: A comparative analysis using general international criteria	15
Exercise response in post-acute coronary syndrome patients survived to COVID-19 infection	15
Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies	15
Endeavor of exploring mechanisms of myocardial infarction in patients with no standard modifiable cardiovascular risk factors	15
A retrospective study: Long term prognosis in adults with PA-VSD-MAPCAs	15
Antiplatelet therapy in percutaneous coronary intervention: Can we expect a revival of the use of parenteral agents?	15
Comparison of heart failure therapy and outcomes between the 2016–2020 and 2021–2023 cohorts: A retrospective cohort study	15
Submariners unplugged: Unmasking pre-metabolic syndrome and its associated factors in deep blue	15
Temporal changes in incidence, treatment strategies and 1-year re-admission rates in patients with atrial fibrillation/flutter under 65 years of age: A Danish nationwide study	15
Cardiopulmonary exercise testing: Time to rethink the validity of non-metabolic thresholds?	15
MINOCA in Men and Women: Different Conditions and a Single Destiny?	15
Shiny curves, shaky foundations: Bias and reliability in no-reflow prediction models	15
Left atrial strains in cardiac amyloidosis -does its subtype matter?	15
Editorial Board	15
Glycemic control and coronary plaque characteristics in patients with acute myocardial infarction	15
Insights of upregulating of DDAH2 expression by pharmacological action	15
Differences in fellowship and practice among heart failure specialist (HFS) and non-HFS within Asia Pacific	15